26 September 2019 (Thursday) - Oncologist Update

The nice people from “The Oncologist” sent their update today. As always it focussed on treatments and clinical matters rather than the more scientific or technical, but background information is always good…

Most-Cited Articles in Hematology Oncology

Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents Bruce D. Cheson, Sari Heitner Enschede, Elisa Cerri et al. FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Elizabeth Dianne Pulte,  Andrew Dmytrijuk, Lei Nie et al. EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma Kyriaki Tzogani,  Paula van Hennik, Ita Walsh et al. Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma Douwe Postmus,  Sarah Richard,  Nathalie Bere et al.

Most-Cited Articles in Medical Oncology

Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval Sean Khozin, Amy P. Abernethy, Nathan C. Nussbaum et al. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma Silvia Stacchiotti, Olivier Mir, Axel Le Cesne et al. A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer Kristen K. Ciombor, Tanios Bekaii‐Saab Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing Nirali M. Patel, Vanessa V. Michelini, Jeff M. Snell et al.